{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:23:34Z","timestamp":1790540614020,"version":"4.1.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Context<\/jats:title><jats:p>Disseminated infections due to <jats:italic>Mycobacterium bovis<\/jats:italic> Bacillus Calmette-Gu\u00e9rin (BCG) are unusual and occur mostly in patients with inborn error of immunity (IEI) or acquired immunodeficiency. However, cases of secondary BCGosis due to intravesical BCG instillation have been described. Herein, we present a case of severe BCGosis occurring in an unusual situation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Description<\/jats:title><jats:p>We report one case of severe disseminated BCG disease occurring after hematological malignancy in a 48-year-old man without BCG instillation and previously vaccinated in infancy with no complication. Laboratory investigations demonstrated that he was not affected by any known or candidate gene of IEI or intrinsic cellular defect involving IFN\u03b3 pathway. Whole genome sequencing of the BCG strain showed that it was most closely related to the <jats:italic>M. bovis<\/jats:italic> BCG Tice strain, suggesting an unexpected relationship between the secondary immunodeficiency of the patient and the acquired BCG infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case highlights the fact that, in addition to the IEI, physicians, as well as microbiologists and pharmacists should be aware of possible acquired disseminated BCG disease in secondary immunocompromised patients treated in centers that administrate BCG for bladder cancers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.696268","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T07:47:58Z","timestamp":1627976878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy"],"prefix":"10.3389","volume":"12","author":[{"given":"Vincent","family":"Gies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Dieudonn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimir","family":"Sougakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Carapito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Weingertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Jacquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Hubele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Kuhnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Danion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Korganow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Guffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00652-1","article-title":"Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies","volume":"39","author":"Liew","year":"2019","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian Susceptibility to Mycobacterial Disease: Genetic, Immunological, and Clinical Features of Inborn Errors of IFN-\u03b3 Immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.10.037","article-title":"The Genetic Heterogeneity of Mendelian Susceptibility to Mycobacterial Diseases","volume":"122","author":"Al-Muhsen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.01.038","article-title":"Primary Immunodeficiency Diseases and Bacillus Calmette-Gu\u00e9rin (Bcg)-Vaccine-Derived Complications: A Systematic Review","volume":"8","author":"Fekrvand","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.045","article-title":"T Cell Susceptibility to HIV Influences Outcome of Opportunistic Infections","volume":"155","author":"Saharia","year":"2013","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1086\/498315","article-title":"Incidence of Tuberculosis Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2020.1742475","article-title":"Disseminated BCG Sepsis Following Intravesical Therapy for Bladder Carcinoma: A Case Report and Review of Literature","volume":"10","author":"Oladiran","year":"2020","journal-title":"J Community Hosp Internal Med Perspect"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e362845","DOI":"10.1155\/2014\/362845","article-title":"Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment","volume":"2014","author":"To","year":"2014","journal-title":"Case Rep Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau8714","article-title":"Tuberculosis and Impaired IL-23-Dependent IFN-\u03b3 Immunity in Humans Homozygous for a Common TYK2 Missense Variant","volume":"3","author":"Boisson-Dupuis","year":"2018","journal-title":"Sci Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70196-1","article-title":"Anticytokine Autoantibodies in Infectious Diseases: Pathogenesis and Mechanisms","volume":"10","author":"Browne","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062505","article-title":"Gm-Csf Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis","volume":"356","author":"Uchida","year":"2007","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19316","article-title":"Acquired Predisposition to Mycobacterial Disease Due to Autoantibodies to IFN-\u03b3","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (Bcg) Infection Following Intravesical Bcg Administration as Adjunctive Therapy For Bladder Cancer","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2014","journal-title":"Med (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/821526","article-title":"Systemic BCG-Osis as a Rare Side Effect of Intravesical Bcg Treatment for Superficial Bladder Cancer","volume":"2013","author":"Lukacs","year":"2013","journal-title":"Case Rep Urol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215599","article-title":"Systemic BCG Infection in a Patient With Pancytopaenia and Fever 9","volume":"2016","author":"Westhovens","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2018.11.014","article-title":"Bacillus Calmette-Guerin Infection Following Intravesical Instillation: Does the Strain Matter","volume":"49","author":"Levi","year":"2019","journal-title":"Med Mal Infect"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.3.662","article-title":"Mycobacterial Brain Abscess Possibly Due to Bacille Calmette-Gu\u00e9rin in an Immunocompromised Child","volume":"14","author":"Coppes","year":"1992","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508313330905","article-title":"Meningitis Due to Iatrogenic Bcg Infection in Two Immunocompromised Children","volume":"333","author":"Stone","year":"1995","journal-title":"New Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1086\/313652","article-title":"Nosocomial Transmission of Mycobacterium Bovis Bacille Calmette-Guerin to Children Receiving Cancer Therapy and to Their Health Care Providers","volume":"30","author":"Waecker","year":"2000","journal-title":"Clin Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1086\/379034","article-title":"Nosocomial Mycobacterium Bovis-Bacille Calmette-Gu\u00e9rin Infections Due to Contamination of Chemotherapeutics: Case Finding and Route of Transmission","volume":"188","author":"Vos","year":"2003","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix496","article-title":"Healthcare-Associated Mycobacterium Bovis-Bacille Calmette-Gu\u00e9rin (Bcg) Infection in Cancer Patients Without Prior BCG Instillation","volume":"65","author":"Meije","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.696268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T07:48:00Z","timestamp":1627976880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.696268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2021.696268"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.696268","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"article-number":"696268"}}